Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01319305 · ClinicalTrials.gov registry record
BREATHE Long-Term Follow-Up Study
A clinical trial, sponsored by Entellus Medical.
- Completed
- Registry status
- 70
- Enrollment target
NCT01319305: Completed study, sponsored by Entellus Medical.
NCT01319305 is a clinical trial that has completed, run by Entellus Medical. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01319305 has completed, sponsored by Entellus Medical.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
This is a long-term follow-up of patients that participated in the BREATHE I study.
Primary Outcome
Assess post-procedure outcomes defined as SNOT-20 scores and work productivity assessment questionnaires aproximately 24 months post-procedure
Interventions
- DEVICE FinESS Sinus Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2010-04 |
What the finished NCT01319305 record still lists
NCT01319305 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which FinESS Sinus Treatment is the first listed.
NCT01319305 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01319305 about?
NCT01319305 is a clinical study titled "BREATHE Long-Term Follow-Up Study". This is a long-term follow-up of patients that participated in the BREATHE I study.
What is the current status of trial NCT01319305?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2010-04.
What interventions are being tested in trial NCT01319305?
The interventions under investigation include: FinESS Sinus Treatment (DEVICE).
Who is sponsoring clinical trial NCT01319305?
This trial is sponsored by Entellus Medical, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia